For Sponsors

The Johns Hopkins Clinical Research Network offers industry a unique opportunity to conduct clinical research studies in the Mid Atlantic U.S. region. The following Frequently Asked Questions are intended to provide information for sponsors.

FAQs for Sponsors

Expand allClose all

1. What is the Johns Hopkins Clinical Research Network (JHCRN)?

The Johns Hopkins Clinical Research Network is a regional translational research organization linking a preeminent academic medical center with a diverse network of community-based health care delivery systems. We collaborate with both the private and public sector to more rapidly and cost effectively expedite scientific discovery through clinical trials and comparative effectiveness research to improve the care and health of patients.

• JOHNS HOPKINS MEDICINE INSTITUTIONS:
o The Johns Hopkins Hospital, Baltimore, MD
o Johns Hopkins Bayview Hospital, Baltimore, MD
o Howard County General Hospital, Columbia, MD
o Sibley Memorial Hospital, Washington, DC
o Suburban Hospital, Bethesda, MD,
o All Children’s Hospital, St. Petersburg, FL

• AFFILIATE MEMBER INSTITUTIONS:
o Anne Arundel Medical Center, Annapolis , MD
o Greater Baltimore Medical Center, Towson, MD
o Inova Health System, Falls Church, VA
o Peninsula Regional Medical Center, Salisbury, MD
o Reading Hospital and Reading Health System, Reading, PA

Posted in: FAQs for Sponsors

2. Who should sponsors and CROs contact if interested in bringing a study to the JHCRN?

The Johns Hopkins Clinical Research Network can be contacted by any of the following:

• Website: http://ictr.johnshopkins.edu/service/JHCRN
• Phone: 443-287-4000
• E-mail: jhcrn@jhmi.edu
• Director: Dr. Adrian Dobs: adobs@jhmi.edu
• Co-director: Dr. John Niederhuber: John.Niederhuber@inova.org.

Posted in: FAQs for Sponsors

3. What information should sponsors and CROs provide for the JHCRN to consider a study?

a. Study information (title, synopsis, patient population, eligibility criteria),
b. Funding information (if available),
c. Confidentiality Disclosure Agreement (CDA) template, and
d. Feasibility questionnaire.

Posted in: FAQs for Sponsors

4. How do JHCRN sites decide which studies they would like to participate in?

Each site will review study materials and make a decision regarding their participation based on the following criteria:

• Study population,
• Site resources,
• Investigator interest and experience,
• Protocol complexity, and
• Funding

Posted in: FAQs for Sponsors

5. What are the benefits of using the JHCRN?

• One dedicated experienced Network Coordinator for each JHCRN site,
• Access to a large and diverse pool of patients,
• One prime contract with Johns Hopkins,
• One main IRB, Johns Hopkins Medicine IRB, and
• One budget.

Posted in: FAQs for Sponsors

6. What is the Network Coordinator role?

Each JHCRN site has an assigned network coordinator who liaisons between the Johns Hopkins investigator, JHCRN site investigator, and their respective research teams. Responsibilities include:

• Facilitating the identification, prioritization, and implementation of clinical trials jointly approved by JH and network site investigators,
• Developing and implementing effective workflow processes between JHU and the network site in opening research studies, and
• Serving as a main point of contact for both institutions.

Posted in: FAQs for Sponsors

7. How do sponsors and CROs identify a principal investigator for a study?

A JHCRN network coordinator can help you identify a JHU principal investigator. Coordinator contact information can be found at: http://ictr.johnshopkins.edu/clinical/clinical-resources/human-subjects-research-core/jhcrn/jhcrn-network-coordinators/.

Posted in: FAQs for Sponsors

8. Does each JHCRN site have its own principal investigator?

There is one principal investigator for each study who is a Johns Hopkins employee. A lead site investigator is designated at each JHCRN site who is accountable for local study oversight under the direction of the Johns Hopkins principal investigator.

Posted in: FAQs for Sponsors

9. Does the JHCRN have a site management plan?

Yes. It is available upon request.

Posted in: FAQs for Sponsors

10. How does the principal investigator oversee study conduct at JHCRN sites?

The Johns Hopkins principal investigator and lead site investigator(s) communicate regularly about all study activities to ensure quality and integrity of each study.

Posted in: FAQs for Sponsors

11. Who takes responsibility for reporting adverse events from the Network sites to IRB, sponsor, and other regulatory agencies?

The site investigator notifies the principal investigator (PI) of any event meeting expedited reporting requirements as soon as possible. Event reporting to sponsor will first be completed by the principal investigator or site investigator. The PI will determine this reporting responsibility at the onset of a study, and also report to the JHM IRB, and other regulatory agencies as required.

Posted in: FAQs for Sponsors

12. Who does the sponsor and CRO correspond with at the affiliate sites, the JHCRN network coordinator or research staff?

Prior to study start-up, the network coordinator will be the main point of contact to help research staff get started. The network coordinator may have some contact with the sponsor/CRO after start up, but it is preferred they correspond with the research staff directly.

Posted in: FAQs for Sponsors

13. Do sponsors and CROs negotiate budgets and contracts with each JHCRN site?

No. There is one budget and one contract between sponsor and JHU that includes costs for the JHU principal investigator and JHCRN site(s). A JHU budget specialist develops and negotiates all study budgets for the JHCRN.

Posted in: FAQs for Sponsors

15. Where does monitoring take place and where are regulatory documents kept?

Routine study monitoring occurs at both the main Johns Hopkins central site as well as at each participating JHCRN site. The sponsor’s monitor arranges visits with individual sites on mutually convenient dates. Regulatory documents are maintained by the PI’s team at Johns Hopkins for all participating JHCRN sites.

Posted in: FAQs for Sponsors

16. Who ensures research staff at JHCRN sites are appropriately trained in the conduct of human subjects’ research?

The Johns Hopkins Medicine IRB requires human subjects research compliance training, both initial and continuing, be completed by each investigator and other study team member(s).

Posted in: FAQs for Sponsors